ACA |
Aminocephalosporinic acid |
AI |
Artificial intelligence |
AMP |
Antimicrobial peptides |
AMR |
Antimicrobial resistance |
APA |
Aminopenicillanic acid |
APDI |
Antimicrobial photodynamic inactivation |
ATCC |
American type culture collection |
BGC |
Biosynthetic Gene Clusters |
BLDB |
Beta-Lactamase DataBase |
BLI |
β-Lactamase inhibitors |
CF |
cystic fibrosis |
CNAI |
Cross-linked chitosan nanoparticles |
CPE |
Carbapenem-producing Enterobacteriaceae
|
CRISPR/Cas |
Clustered regularly interspaced short palindromic repeats and CRISPR-associated protein |
DBO |
Diazabicyclooctanones |
DHP-I |
Dehydropeptidase-I |
DTR |
Difficult to treat |
EPI |
Efflux pump inhibitor |
ESBL |
Extended spectrum β-lactamase |
FLAP |
Fingerprint for Ligands and Proteins |
ICU |
Intensive care units |
IS |
Insertion sequences |
LGFE |
Ligand-grid Free Energy |
MBL |
Metallo-β-lactamases |
MDR |
Multidrug resistance |
MDS |
Molecular dynamic simulations |
MGE |
Mobile genetic elements |
MIC |
Minimum inhibitory concentration |
MIF |
Molecular Interaction Fields |
ML |
Machine learning |
MRSA |
Methicillin resistant Staphylococcus aureus
|
NMP |
1-(1-napthylmethyl)-piperazine |
NN |
Neural networks |
Nps |
Nanoparticles |
OM |
Outer membrane |
ORF |
Open reading frame |
PAβN |
Phenylalanyl arginyl β-naphthylamide |
PBP |
Penicillin binding proteins |
RF |
Random-forest scoring |
RND |
Resistance-Nodulation-Division |
SBL |
serine β-lactamases |
SILCS |
Site-Identification by Ligand Competitive Saturation |
UTI |
Urinary tract infections |
VAP |
Ventilator associated pneumonia |
WHO |
World Health Organization |
XP |
Extra Precision |